Navigation Links
Product improves peptide identification for proteomics research

Agilent Technologies Inc. (NYSE: A) today introduced a high-performance ion trap mass spectrometer (MS) that allows pharmaceutical and academic life-science researchers to identify 60 to 80 percent more peptides than preceding models in proteomics applications, such as protein identification and biomarker discovery, potentially leading to a better understanding of diseases like cancer and speeding drug development efforts. The Agilent 1100 Series LC/MSD Trap XCT Ultra offers significantly improved scan cycle times, enabling collection of mass spectra at rates up to three times faster than its predecessors.

"The combination of the new LC/MSD Trap XCT Ultra with Agilent's breakthrough HPLC-Chip/MS technology will set a new standard for protein identification and analytical performance," said Ken Imatani, product marketing manager for Agilent's ion trap mass spectrometers. "The high resolution, scan speed and sensitivity of the LC/MSD Trap XCT Ultra make it a powerful tool for a wide range of qualitative applications in which high performance and productivity are essential, particularly in proteomics research."

"The LC/MSD Trap XCT Ultra is the latest example of Agilent's integrated approach to facilitating proteomics research, enabling researchers to solve their most challenging scientific questions more easily and with greater confidence," said Taia Ergueta, general manager of Agilent's Proteomics and LC/MS business. "The LC/MSD Trap XCT Ultra improves performance for a wide range of demanding applications in metabolite characterization, natural products screening, product degradation studies and food and environmental analysis, which require excellent sensitivity and fast scanning capability."

The LC/MSD Trap XCT Ultra, which is based on an advanced multipole ion trap technology, has a full-scan MS/MS sensitivity specification of 250 femtograms for reserpine. The system also has two new data-dependent neutral-loss analysis modes that provide e nhanced data quality for analysis of phosphopeptides and glycopeptides.

The LC/MSD Trap XCT Ultra will be unveiled at the American Association for Cancer Research annual meeting, April 15-20 (Booths 181 and 183).


The Agilent 1100 Series LC/MSD Trap XCT Ultra ion trap mass spectrometer (G4533AA) includes mass spectrometer, electrospray ionization source, data system and LC/MSD Trap software (6.0). It is expected to ship in July 2005. Further information is available at
About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global technology leader in communications, electronics, life sciences and chemical analysis. The company's 28,000 employees serve customers in more than 110 countries. Agilent had net revenue of $7.2 billion in fiscal year 2004. Information about Agilent is available on the Web at



Related biology news :

1. Products containing specific probes for detecting alternative splice forms protected
2. Affymetrix and ParAllele Launch Industrys Most Comprehensive Product Line for Targeted Genotyping
3. Production of key Alzheimers protein monitored for first time in humans
4. Stem cell treatment improves mobility after spinal cord injury
5. Combination therapy improves AIDS-related lymphoma outcome
6. One fish, two fish: New MIT sensor improves fish counts
7. Man-made heart tissue improves cardiac performance
8. Viagra improves high altitude exercise performance up to 45% for some
9. Quitting smoking improves lung function considerably
10. Melatonin improves mood in winter depression
11. Brain protein improves stroke symptoms in rats, even when injected after 3 days
Post Your Comments:

(Date:4/5/2017)... , April 4, 2017 KEY FINDINGS ... to expand at a CAGR of 25.76% during the ... is the primary factor for the growth of the ... MARKET INSIGHTS The global stem ... technology, application, and geography. The stem cell market of ...
(Date:4/3/2017)... 3, 2017  Data captured by IsoCode, ... detected a statistically significant association between the ... treatment and objective response of cancer patients ... predict whether cancer patients will respond to ... well as to improve both pre-infusion potency testing ...
(Date:3/30/2017)... 30, 2017 The research team of The ... (3D) fingerprint identification by adopting ground breaking 3D fingerprint minutiae recovery ... of speed and accuracy for use in identification, crime investigation, immigration ... ... A research team ...
Breaking Biology News(10 mins):
(Date:10/9/2017)... ... 2017 , ... At its national board meeting in North Carolina, ARCS® ... Departments of Physics and Astronomy, has been selected for membership in ARCS Alumni ... the 2015 Breakthrough Prize in Fundamental physics for the discovery of the accelerating expansion ...
(Date:10/9/2017)... ... October 09, 2017 , ... ... the medical journal, Epilepsia, Brain Sentinel’s SPEAC® System which uses the surface ... detecting generalized tonic-clonic seizures (GTCS) using surface electromyography (sEMG). The prospective multicenter ...
(Date:10/7/2017)... ... October 06, 2017 , ... ... ProxiMeta™ Hi-C metagenome deconvolution product, featuring the first commercially available Hi-C kit. ... to perform Hi-C metagenome deconvolution using their own facilities, supplementing the company’s ...
(Date:10/6/2017)... Boston, Mass. (PRWEB) , ... October 06, 2017 ... ... spotlight female entrepreneurship within the healthcare and technology sector at their fourth annual ... six panels featuring 30 inspiring speakers and the ELEVATE pitch competition showcasing early ...
Breaking Biology Technology: